SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001393825-20-000085
Filing Date
2020-02-07
Accepted
2020-02-07 15:24:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 SNCA 13G/A snca_13ga.htm SC 13G/A 56013
  Complete submission text file 0001393825-20-000085.txt   57735
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Subject) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86724 | Film No.: 20587081
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017 212-571-1244
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

IRS No.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A